Interviews
Interviews and expert profiles with pharmaceutical leaders exploring drug discovery, clinical development, regulatory policy and innovation shaping the life sciences industry.
Is AI Quietly Creating a GDPR Crisis in Clinical Research?
How AI Is Reshaping Data Integrity in Pharma Manufacturing
Expert Interview Series
Conversations with pharmaceutical and life sciences leaders exploring drug discovery, clinical development and industry innovation. Watch and listen to insights shaping the future of healthcare.
Explore All Interviews
Explore conversations with pharmaceutical and life sciences leaders covering drug discovery, clinical development and the latest trends shaping science, policy and innovation.
Is AI Quietly Creating a GDPR Crisis in Clinical Research?
Generative AI is transforming clinical trials, but a failure to distinguish between pseudonymised and anonymised data is creating costly regulatory gaps.
How AI Is Reshaping Data Integrity in Pharma Manufacturing
Veragence CEO Nour AlSaleh discusses how AI is transforming data integrity in pharma manufacturing, regulatory compliance, the "human-in-the-loop" requirement, and patient safety in the era of AI-driven GxP systems.
AI in Pharma: Why the Future of Healthcare Starts With Patients, Not Tech
Kate O’Reilly, President & Chair of the Healthcare Businesswomen’s Association (HBA) Dublin-Ireland Chapter & Healthcare Transformation Partner at Roche, discusses AI in pharma, patient engagement, and the future of healthcare innovation.
AI in Pharma: Hype vs. What Actually Works
Expert Lara Masad explains why pharma leaders miscalculate AI investments and how to build a defensible validation strategy.
How Cortical Implants Are Opening a New Era of Vision Restoration
By directly stimulating the visual cortex instead of relying on the retina or optic nerve, ReVision's FDA Breakthrough Device-designated implant could make vision restoration possible for millions of patients who have no existing treatment options.
How Clinical Research Shapes Cardiac Device Innovation
Dr David Hayes explains why clinical research should be embedded early in cardiac device development and not treated as a late-stage compliance step.